<SEC-DOCUMENT>0001193125-24-239193.txt : 20241018
<SEC-HEADER>0001193125-24-239193.hdr.sgml : 20241018
<ACCEPTANCE-DATETIME>20241018064601
ACCESSION NUMBER:		0001193125-24-239193
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20241017
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241018
DATE AS OF CHANGE:		20241018

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		241378876

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d837701d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20241017" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2024-10-17_to_2024-10-17">CVS HEALTH Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-286">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-10-17_to_2024-10-17">0000064803</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cvs-20241017.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-10-17_to_2024-10-17"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-10-17</xbrli:startDate> <xbrli:endDate>2024-10-17</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, DC 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-297">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(D)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-10-17_to_2024-10-17" format="ixt:datemonthdayyearen" id="ixv-298">October 17, 2024</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img src="g837701g1017200902113.jpg" alt="LOGO"/></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">CVS HEALTH CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-10-17_to_2024-10-17" format="ixt-sec:stateprovnameen" id="ixv-299">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-300">001-01011</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-301">05-0494040</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction<br/>of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-302">One CVS Drive</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-303">Woonsocket</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-10-17_to_2024-10-17" format="ixt-sec:stateprovnameen" id="ixv-304">Rhode Island</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-305">02895</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices, and Zip Code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-306">(401)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-307">765-1500</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name, former address and former fiscal year, if changed since last report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-10-17_to_2024-10-17" format="ixt-sec:boolballotbox" id="ixv-308">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-10-17_to_2024-10-17" format="ixt-sec:boolballotbox" id="ixv-309">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-10-17_to_2024-10-17" format="ixt-sec:boolballotbox" id="ixv-310">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communication pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-10-17_to_2024-10-17" format="ixt-sec:boolballotbox" id="ixv-311">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communication pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-312">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-313">CVS</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-10-17_to_2024-10-17" format="ixt-sec:exchnameen" id="ixv-314">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (17 CFR <span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-10-17_to_2024-10-17" format="ixt-sec:boolballotbox" id="ixv-315">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;2.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Results of Operations and Financial Condition. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information set forth under Item 7.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.02. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October 18, 2024, CVS Health Corporation (the &#8220;<span style="text-decoration:underline">Company</span>&#8221;) announced that the Board of Directors (the &#8220;<span style="text-decoration:underline">Board</span>&#8221;) of the Company appointed J. David Joyner as President and Chief Executive Officer of the Company, effective as of October&#160;17, 2024. Karen S. Lynch ceased to serve as President and Chief Executive Officer of the Company and resigned as a member of the Board on the same day. In connection with Mr.&#160;Joyner&#8217;s appointment as President and Chief Executive Officer of the Company, the Board appointed Mr.&#160;Joyner as a member of the Board and the Executive Committee of the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective October&#160;17, 2024, the Board has also appointed current Chairman Roger N. Farah as Executive Chairman of the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immediately prior to his appointment as President and Chief Executive Officer, Mr.&#160;Joyner, age 60, served as the Executive Vice President and President of Pharmacy Services of the Company since January 2023. Mr.&#160;Joyner previously served as the Company&#8217;s Executive Vice President &#8211; Sales and Account Services, CVS Caremark from March 2011 through December 2019. Mr.&#160;Joyner has served as a Strategic Business Advisor to gWell, Inc., a wellness technology company, since July 2021, an Advisor to Podimetrics Inc., a health care company focused on the identification and treatment of diabetic foot ulcers, since September 2020, and as a member of the Advisory Council to the Rawls College of Business of Texas Tech University since July 2020. Mr.&#160;Joyner formerly served as an Advisor to EQRx, a biopharmaceutical company that aimed to develop and sell lower-cost versions of existing drugs, from November 2020 until January 2023, and as a Special Advisor to BCBS Association, a national federation of independent and locally operated Blue Cross and Blue Shield companies, from February 2022 through October 2022. He also was a member of the boards of directors of HomeFree Pharmacy Services from June 2021 until January 2023 and of Panther Specialty Pharmacy from July 2022 until January 2023. Mr.&#160;Joyner holds a bachelor&#8217;s degree in finance from The Rawls College of Business at Texas Tech University. Mr.&#160;Joyner has no family relationship to the Company nor to any of its directors or executive officers, and there are no transactions in which Mr.&#160;Joyner has an interest requiring disclosure under Item 404(a) of Regulation <span style="white-space:nowrap">S-K.</span> There is no arrangement or understanding between Mr.&#160;Joyner and any other person pursuant to which Mr.&#160;Joyner was appointed as an officer or a director of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with Ms. Lynch&#8217;s departure, she will be eligible to receive the separation benefits applicable upon a &#8220;qualifying event&#8221; (not in connection with a change in control) under her amended and restated employment agreement with the Company, dated November&#160;5, 2020, although with respect to her outstanding equity awards, the partial vesting provisions applicable thereto have been eliminated, such that Ms. Lynch remains eligible to vest in all such awards in full (subject to the achievement of performance metrics with respect to any performance stock unit awards). The receipt of such benefits is contingent upon Ms. Lynch&#8217;s execution of a customary release of claims in favor of the Company and compliance with restrictive covenants. In connection with her departure, the Company and Ms. Lynch entered into a letter agreement (the &#8220;<span style="text-decoration:underline">Lynch Letter Agreement</span>&#8221;) setting forth the foregoing benefits and the agreement with Ms. Lynch to provide advisory services to the Company for a term of six months following her departure. In consideration of the advisory services, during the term, Ms. Lynch will receive a monthly advisory fee of $375,000 and continued Company-provided security services. The Company and Ms. Lynch have agreed to amend her restrictive covenant agreement to extend the <span style="white-space:nowrap">non-competition</span> and <span style="white-space:nowrap">non-solicitation</span> provisions to a period of thirty (30)&#160;months from the date of her departure. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Lynch Letter Agreement is only a summary and is qualified in its entirety by the full text of the Lynch Letter Agreement, a copy of which will be filed as an exhibit to the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ending December&#160;31, 2024. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;7.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October 18, 2024, the Company issued a press release announcing the appointment of Mr.&#160;Joyner as President and Chief Executive Officer of the Company and the departure of Ms.&#160;Lynch, which also included certain preliminary third quarter 2024 results.&#160;A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with General Instruction B.2 of Form <span style="white-space:nowrap">8-K,</span> the information in Item 2.02 and this Item 7.01, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for the purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in Item 2.02 and this Item 7.01 shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">(d) Exhibits </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:5%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit<br/>Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d837701dex991.htm">Press Release, dated October&#160;18, 2024 (furnished under Item 7.01). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">-2- </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom" colspan="3">Date: October&#160;18, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">CVS HEALTH CORPORATION</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kristina V. Fink</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Kristina V. Fink</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Senior Vice President, Chief Governance Officer and Corporate Secretary</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">-3- </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d837701dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PRESS RELEASE </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CVS Health Appoints David Joyner
President and Chief Executive Officer </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Roger Farah Named Executive Chairman of the Board </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Company provides preliminary guidance for third quarter 2024 GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10
</I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WOONSOCKET, RI (October 18, 2024) &#150; CVS Health (NYSE: CVS) today announced that David Joyner was appointed President and Chief Executive
Officer, effective October&nbsp;17, replacing Karen Lynch, who stepped down from her position in agreement with the company&#146;s Board of Directors. Joyner also joined the Board of Directors. In addition, current Chairman of the Board, Roger
Farah, will now be Executive Chairman. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joyner was most recently executive vice president, CVS Health, and president, CVS Caremark. He led the pharmacy
services business, which provides solutions to employers, health plans and government entities and serves approximately 90 million members through Caremark, CVS Specialty, and other areas.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joyner has 37 years of health care and pharmacy benefit management experience, and has also served on the boards of several private equity-backed health care
companies. He began his career at Aetna as an employee benefit representative before joining Caremark Prescription Services as a regional sales manager. He then served as executive vice president of sales and account services at CVS Caremark and
executive vice president of sales and marketing at CVS Health. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The Board believes this is the right time to make a change, and we are confident
that David is the right person to lead our company for the benefit of all stakeholders, including customers, employees, patients, and shareholders,&#148; said Farah. &#147;CVS Health is responsible for improving health for millions of people across
the U.S., and our integrated businesses work together to deliver on our purpose and mission every day. To build on our position of strength, we believe David and his deep understanding of our integrated business can help us more directly address the
challenges our industry faces, more rapidly advance the operational improvements our company requires, and fully realize the value we can uniquely create.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;There is no greater honor than to lead a company whose mission and purpose are completely focused on improving health,&#148; said Joyner. &#147;I came
back to CVS Health in 2023 because I believed I could give more to the company, and I take this opportunity today for the same reason. I am proud to continue working side by side with our 300,000 colleagues who are building a world of health around
every consumer. Every day, CVS Health expands access, drives greater affordability, and achieves better health outcomes for more than 186&nbsp;million people. Aligned with our management team and our Board, I believe in the future of our company and
I am committed to delivering our best every day to everyone we serve.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Farah added: &#147;The Board also recognizes the many contributions Karen
made to our company, both during her tenure at Aetna and then as President and CEO of CVS Health. We are grateful for her consistent, customer-focused leadership, especially during the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic when
our pharmacies provided needed tests and vaccines. We also appreciate her work to advance CVS Health&#146;s modernization and transformation to become a diversified, connected, technology-driven health care company, allowing us to do even more for
the people we are privileged to serve.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with today&#146;s announcement, the Company is also providing preliminary guidance for third
quarter 2024 GAAP diluted EPS of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10. Results for the third quarter include charges to record premium deficiency reserves (PDRs), primarily related to the company&#146;s Medicare and Individual Exchange
businesses inside its Health Care Benefits segment, of approximately $1.1&nbsp;billion, which lowered third quarter 2024 Adjusted EPS by $0.63.&nbsp;The PDRs are expected to be substantially released during the fourth quarter of 2024, benefiting
results in that period.&nbsp;The Company&#146;s GAAP results also include a restructuring charge of approximately $1.2&nbsp;billion, related to incremental store closures in 2025, as well as cost reduction actions discussed on the second quarter
2024 earnings call.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the third quarter of 2024, the Company has continued to experience medical cost trends in excess of those projected in its prior
outlook.&nbsp;The Medical Benefit Ratio (&#147;MBR&#148;) for the third quarter is currently expected to be approximately 95.2%, which includes a <FONT STYLE="white-space:nowrap">220-basis</FONT> point impact from the PDRs.&nbsp;The Company&#146;s
other segments performed consistent with prior projections in the quarter.&nbsp;In light of continued elevated medical cost pressures in the Health Care Benefits segment, investors should no longer rely on the Company&#146;s previous guidance
provided on its second quarter 2024 earnings call on August&nbsp;7, 2024.&nbsp;The Company plans to further update investors on its third quarter 2024 earnings call, currently scheduled for&nbsp;November 6, 2024, after the company has completed its
standard quarterly close processes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s preliminary financial results are based on the Company&#146;s current estimate of its results for
the quarter ended September&nbsp;30, 2024, and remain subject to change based on the completion of closing and review procedures and the execution of the Company&#146;s internal control over financial reporting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Financial Measures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release includes projected Adjusted EPS, which represents a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure. The Company uses <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> financial measures to analyze underlying business performance and trends. The Company believes that providing <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures enhances the Company&#146;s
and investors&#146; ability to compare the Company&#146;s past financial performance with its current performance. <FONT STYLE="white-space:nowrap">Non-GAAP</FONT> financial measures should not be considered a substitute for, or superior to,
financial measures determined or calculated in accordance with GAAP. The Company&#146;s definitions of its <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures may not be comparable to similarly titled measures reported by other
companies. The most directly comparable GAAP measure is projected GAAP diluted EPS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Projected GAAP diluted EPS and projected Adjusted EPS, respectively,
are calculated by dividing projected net income attributable to CVS Health and projected adjusted income attributable to CVS Health by the Company&#146;s projected weighted average diluted shares outstanding. The Company defines adjusted income
attributable to CVS Health as net income attributable to CVS Health (GAAP measure) excluding the impact of amortization of intangible assets, net realized capital gains or losses and other items, if any, that neither relate to the ordinary course of
the Company&#146;s business nor reflect the Company&#146;s underlying business performance, such as acquisition-related integration costs, restructuring charges, office real estate optimization charges, as well as the corresponding tax benefit or
expense related to the items excluded from adjusted income attributable to CVS Health. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following are reconciliations of projected net income attributable to CVS Health to adjusted income
attributable to CVS Health and projected GAAP diluted EPS to Adjusted EPS: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended September&nbsp;30, 2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B></B><B><I>In&nbsp;millions, except per share amounts</I></B><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Company</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Common<BR>Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Company</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Common<BR>Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income attributable to CVS Health (GAAP measure)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">507</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">507</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net realized capital gains</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(19</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(19</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition-related integration costs
<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restructuring charges <SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Office real estate optimization charges
<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax impact of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> adjustments <SUP
STYLE="font-size:75%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(433</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.33</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(433</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.33</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted income attributable to CVS Health</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average diluted shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">During the three months ended September&nbsp;30, 2024, the acquisition-related integration costs relate to the
acquisitions of Signify Health and Oak Street Health. </P></TD></TR></TABLE> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">During the three months ended September&nbsp;30, 2024, the restructuring charges are primarily comprised of a
store impairment charge, other asset impairment and related charges associated with the discontinuation of certain <FONT STYLE="white-space:nowrap">non-core</FONT> assets, as well as corporate workforce optimization costs, including severance and
employee-related costs. During the third quarter of 2024, the Company developed an enterprise-wide restructuring plan intended to streamline and simplify the organization, improve efficiency and reduce costs. In connection with this restructuring
plan, the Company completed a strategic review of its retail business and determined that it would close 271 additional retail stores, and, accordingly, it recorded a store impairment charge to write down the associated operating lease <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets and property and equipment. In addition, during the third quarter of 2024, the Company also conducted a review of its various strategic assets and
determined that it would discontinue the use of certain <FONT STYLE="white-space:nowrap">non-core</FONT> assets, at which time impairment losses were recorded to write down the carrying value of these assets to the Company&#146;s best estimate of
their fair value. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">During the three months ended September&nbsp;30, 2024, the office real estate optimization charges primarily
relate to the abandonment of leased real estate and the related <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets and property and equipment in connection with the Company&#146;s continuous
evaluation of corporate office real estate space in response to its ongoing flexible work arrangement. </P></TD></TR></TABLE> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the corresponding tax benefit or expense related to the items excluded from Adjusted EPS above. The
nature of each <FONT STYLE="white-space:nowrap">non-GAAP</FONT> adjustment is evaluated to determine whether a discrete adjustment should be made to the adjusted income tax provision. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Statement Concerning Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation.
Statements in this press release that are forward-looking include, but are not limited to, references to CVS Health&#146;s estimates for certain financial metrics for the three months ended September&nbsp;30, 2024 presented in this press release,
all of which are preliminary. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ
materially from those contemplated by the forward-looking statements due to the risks and uncertainties described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the heading
&#147;Cautionary Statement Concerning Forward-Looking Statements&#148; in our most recently filed Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and Current
Reports on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are cautioned not to place undue reliance on CVS Health&#146;s forward-looking
statements. CVS Health&#146;s forward-looking statements are and will be based upon management&#146;s then-current views and assumptions regarding preliminary financial estimates and projections, future events and operating performance, and are
applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CVS Health </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital
channels and over 300,000 dedicated colleagues &#151; including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health &#151; whether that&#146;s managing
chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system &#151; and their personal health care &#151; by improving
access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cvs-20241017.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 10/18/2024 2:43:18 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:cvs="http://www.cvshealth.com/20241017"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.cvshealth.com/20241017"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20241017_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20241017_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cvs-20241017_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 10/18/2024 2:43:18 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cvs-20241017_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 10/18/2024 2:43:18 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cvs-20241017.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g837701g1017200902113.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g837701g1017200902113.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  3 )4# 2(  A$! Q$!_\0
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4Z+B'S-JQ,"7;.63)YS1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45672120147136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 17, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 17,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ O35269>*NQS     $P(   L
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( +TU4EFR8[V-/ 0  ((0   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " "]-5)9GZ ;\+$"  #B#   #0              @ & #   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( +TU4EF7BKL<P    !,"   +
M  "  5P/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( +TU4ED<.&7J/P$  #P"
M   /              "  440  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" "]-5)9)!Z;HJT   #X 0  &@              @ &Q$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "]-5)999!YDAD!  #/ P
M$P              @ &6$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"  #@$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d837701d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cvs-20241017.xsd</File>
    <File>cvs-20241017_lab.xml</File>
    <File>cvs-20241017_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d837701d8k.htm">d837701d8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g837701g1017200902113.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d837701d8k.htm": {
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20241017",
   "dts": {
    "schema": {
     "local": [
      "cvs-20241017.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20241017_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20241017_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d837701d8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-10-17_to_2024-10-17",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d837701d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-10-17_to_2024-10-17",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d837701d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.cvshealth.com//20241017/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-24-239193-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-239193-xbrl.zip
M4$L#!!0    ( +TU4EG=QVMU0 ,  $T+   0    8W9S+3(P,C0Q,#$W+GAS
M9+U6VV[;.!!]+]!_F-53%ZA$R^XE$>(4W4T#!$C3PDF+OA6T-+:)4J26I)+X
M[SND)$=V8J^3+#8OH3AS#L]<./31A]M2PC4:*[0:1VDRB !5K@NAYN.HMC&W
MN1#1A^.7+X[^B&,X.3V[@!@6SE4V8^SFYB8I9D)9+6M'##;)=<D@CCO_OZ^^
MP?>&/8,)2N06H>36H8&_:B&+;#@8CM)!.DR&?9A![OF@X XS2 <L/6#D^0:&
MV9M1EA[ U\_P*= HN!(E]K&Z6AHQ7SAXE?\) 72BE4(I<0FG0G&5"R[ALI/\
M&LY4GL!'*6'B899T6C376"0MZZTM,ILOL.0O7P!0PI3-%%'6Y3CRF6@3<3LU
M,M%FS@IGF%M6R,@I)B\T(H]ZT'_'W<-0);S%KH S;J<!U%E\>D8]1'YMUTZA
M[P5RZ1:A1#XME/7W/4"!8@4(DBSFR5Q?,S)LDGN[>#B(X6 P8M01CO*,/8@4
MZM<.A#=/J3GZA]R#W(P"(#T\/&3!NB&I<.L1M.QO66,,WMPY(Z:UPU-MRA.<
M\5H2JE;_U%R*F< B>%&GEJC<FL^ZA^-FCNZ"EV@KGN/C<DT=]5!@I#5E/SZ?
M7X9FBXX] "#TGR@K;1PT;7BN\W ]=N33?\5=&6*_%:?#>)0F1!:!>E#VEAH"
M>[:0KKI/$K)JC;V%V&TM[!>Q7VP[_>'&?W(&-F^TC__0QY^^VRO^>Q/A/U"B
MU<5SQ?3&VM-KHKC(FZG5+/>ORQWR6;W9C06?A[<[#]Z<(^VIX4RNE';AH+X2
M7E5"S72[19N^B;.NDR<X@S"_,FYRHR7NGG*L,KI"XP1-^;O+T! L#,[&$0V<
MN!LS/R6?)C1F.H][_.NWRYL905">WZGKL$XX#S[W9O!V>BVY7%'[;AA'EM(N
M>[?S_XVV,OC8: EB:;B'HFT/^FO/Z]&Q^W.NR /\XMOD;,?SL'H?F..W6NER
MV:@\T7GMWZ#N_T=5?%*D;7E&C67*H"L"00_)A-Q_[N6^4MGI+)!^O8G0O>G
M_]&/NXZAO^2J@(8.>GQ';)-DD[^V6'Q1QV&=<YG7<I7U%MQZ[ )NUFM_Y)VR
M[;AVMZM8=XO9YC5N=_K7O=EJQ@U]_@902P,$%     @ O35261L4Y:E@!@
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MI^+,9Q>.A*@NP5=M.Y#_PU;(=720F@<LL(]-;H[8-_L0();\!5!+ P04
M" "]-5)9Q/#3.!$7  #/?@  #@   &0X,S<W,#%D.&LN:'1M[5UM4^.XLO[.
MKU!ESYZ%*I+821@@,)QB K/#S@QP$W;WW/ME2[&51&<<*RO;D-Q??[M;LF/G
M!4((L+.7K=HACF6IU>J7IULMY_A?XV' ;H6.I K?_^16G)^8"#WER[#__J?3
M3NOBXJ=_G6P=#V)H!DW#J.D+^;XTB.-1LUH==W50B817Z:O;*MRHUIQ:O60;
M)E$YGHQ$E+7N\:A;4;I?3>\4FH<J#)-AUOCN[JY"W>,#?JRK^$05&I6AE=#2
M2Y\;!S+\5GCLKDX/N8>'AU6ZFS:=:YD-4'.<>A5O=WDDTN;>;51H#=<#P8-X
M4/'4$&EON(Z[G]$1R4540,]N]=]?OW2\@1CRL@RCF(=>-D82ZZ44'5;A;MI0
M1JI1<_?O(=^VR!X8+VOK0ML0)BO^_:']9=H\7MQ^VK0::QY&/:6'/ 9QP9[V
MRDZM7'N7ZZ0,XE#H*!6/A_HY*-?=C)<PN+QOJC-<Q+O^C%C:QN^JYJ9MNEQ0
M4,1+*.J"^_ GEG$@3@[*GX^KYN/6\5#$G.'C9?%G(F_?EUHJC$48EV] -$O,
M,U?O2[$8QU7JK@I/54V'C+'CKO(G)\>^O&51/ G$^Y(OHU' )RC[HG3"CN6X
MB:V%MI^E[XO0?(8FET;PF?3?ES[1K3] Y_XX#X' 25OT982,C2_Y$*@)X5\8
M0,CFXOM$[3ANBQZT2C2MQ!\HTV77*;O[?\0J=U4Z:?W689_.3[_<?&(MI4?'
MU0))<R1.1S\=BM"'_^./ >\_=EB:JAS?EFL'[THG/1Y$XJ&1%S*G!>-K'ER$
MOAA_%I-Y[LPU>"1['/SO7>/ J<_35YU922UZ0H.1%1%<H\UI1F0;8*SG-&DT
M$AK1]Z5(#D=!]MU XR3!N)53DU891WYZEVM/*Y35A\>HVLD6)DC7D4JTN23-
M;EKNTF*MP-WT,4%KE5U*'[_H2:$9<5 LM#NMB\_%]9E]&*E>V/\(%E#YV268
M'!V?\5B<3&E+GYS>F]+J+VF;WLF&S<:I%KB3<7/*O6K>0%3!D,"?G#G!I\H\
MD/VPZ<%<A"X5[]])/QXT#RI[,CS*M0U$+SX:<MV781D_-QE/8I5^HV5_8+_"
M[D9I9VC-RP-!=P$WC+(N8C5JYBZ[*H[5D+[I*@VDI]^XHS&+5"!]]@,MCU,Z
M^></[COGZ+@Z6C90_>&!:FL/E.NV 9VP^0FP'BQ-.9+_*YKN07;=XT,93)HW
M<B@B=BGN6%L->7A$]^X,W5T5^$<+EN?7RXN;\S/6N3F].>\L)\=Y(7(ZYZU?
MVQ<W%^<==GIYQL[_W?IT>OGS.6M=??UZT>E<7%T^B<;:)FC\G4<#0*>Q"G?9
M68O5G+W&X0Q5TR$/5A#+HC0\I$X+Q?+=6F)9<:!943*/C(K6W!_GI[ZBBDXG
MDUJ(1:MU\$(2]?&J_94=1R,>9D9H(&-1AF\\ 7[R3O-1Z60I>CA37H+@(8>P
MU@ /A^!#",D57?-Q%>DZ>1.>9Q">C:@Z&*/V^>4-:Y]?7[5O7M_T7/_:[OQZ
M"@3=7#$PE3=@#YE;9U=MYNYMG^V\/H%7']G-IW.6,^.9"3]MW3"X[1[6&\OI
M?*F%1?S#5(]I,5(Z9MOIM>" ?T04,W$++>UMX>\TE\<7J86X)A!U;K#5HTV%
M"4;17,1-'SH8PN,#GT\F0)$(\Z;D +CLQ:H+H-/=WV78R;Q=>3,H*QB4I_!E
MF9+-R^X"MFT=RV&?1=I[7^H?U/?W';>/40]F7)R:Z]8K_QE!I,H#D(<O5S]?
M05SS%(VI-3:A,44?RC#+4I;CLHDKFP]E PKA^U4;K.GI#8$Y<H#L28;+V<3T
MML_'W(L9$HMV8$H^XQ'KC(2'D9K/9,A: XBTA)XUMF]*MG$EVSJ.>3<0S!-!
M@' -4\(EIT37(^[[Z;4=R<[44T' 1Y%HIA_N%PY6)-#PPG6<'RWGFHZELNFD
M(2C0I>E?OQC7UAL_8@HB?^-6Z%AZ/+!,-1.=;62?KJWV=$KB7.M\-\=52Z).
M[XYX7Y2[6O!OF *6OFCR6P5"L#)W7%J>PH@L)R^L(#!-$A4V,P%8=H#:>3LR
MJYKW('%C5RY"3VEPRN1/.S%XRI9*PEA/6LI_DM=%@X99E%B,M+K%88MN]Q!
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MZ\*9FKFA0 $3LOYX%T?8S=%(-B<U,MP,"HXLZZ1GHKQ_U/?W=AW'L4N/,I;
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M^3HA-/4GJ7( WX#P.+!X/1-WF5WC:='D2J'G@J,=/N[C>YSJ5"AFM+\! L-
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M/&;P [<X%?\#%[3^#I#G G# XI;N7-,EY3T@P\'N%WS(1XS_/U!+ P04
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MRVUI0[2&DZIT@]#^S[H8*R"1._T'4$L! A0#%     @ O3526=W':W5  P
M30L  !               ( !     &-V<RTR,#(T,3 Q-RYX<V102P$"% ,4
M    " "]-5)9&Q3EJ6 &  "_0P  %               @ %N P  8W9S+3(P
M,C0Q,#$W7VQA8BYX;6Q02P$"% ,4    " "]-5)99/)?=K<$  !^*@  %
M            @ $ "@  8W9S+3(P,C0Q,#$W7W!R92YX;6Q02P$"% ,4
M" "]-5)9Q/#3.!$7  #/?@  #@              @ 'I#@  9#@S-S<P,60X
M:RYH=&U02P$"% ,4    " "]-5)9!-Z=Y0H8  !I?   $0
M@ $F)@  9#@S-S<P,61E>#DY,2YH=&U02P$"% ,4    " "]-5)9CZY+:U8(
M  #>"   &0              @ %?/@  9S@S-S<P,6<Q,#$W,C P.3 R,3$S
:+FIP9U!+!08     !@ & (0!  #L1@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d837701d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20241017.xsd" xlink:type="simple"/>
    <context id="duration_2024-10-17_to_2024-10-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2024-10-17</startDate>
            <endDate>2024-10-17</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2024-10-17_to_2024-10-17"
      id="Hidden_dei_EntityRegistrantName">CVS HEALTH Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-286">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-10-17_to_2024-10-17"
      id="Hidden_dei_EntityCentralIndexKey">0000064803</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-297">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-298">2024-10-17</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-299">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-300">001-01011</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-301">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-302">One CVS Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-303">Woonsocket</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-304">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-305">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-306">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-307">765-1500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-308">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-309">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-310">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-311">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-312">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-313">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-314">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-10-17_to_2024-10-17" id="ixv-315">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
